Highpoint Hospice 575 East Bledsoe Street Suite 9, Gallatin, TN, 37066 | |
(615) 532-8669 |
News Archive
Researchers at Cincinnati Children's Hospital Medical Center have developed the first molecular test to diagnose eosinophilic esophagitis, a chronic upper gastrointestinal disorder. The incidence of EoE has skyrocketed since it was first characterized two decades ago.
VistaGen Therapeutics, Inc. and NuPotential, Inc. today announced that the National Heart, Lung and Blood Institute of the U.S. National Institutes of Health (NIH) has awarded to the companies a grant of approximately $500,000 to accelerate development of novel and safer approaches to generate patient-specific induced pluripotent stem (iPS) cells for regenerative medicine, drug discovery and drug rescue.
Tumor burden plays an independent prognostic and predictive role in metastatic renal cell carcinoma, a clinical trial shows.
Because half of all instances of hearing loss are linked to genetic mutations, advanced gene research is an invaluable tool for uncovering causes of deafness - and one of the biggest hopes for the development of new therapies. Now Prof. Karen Avraham of the Sackler Faculty of Medicine at Tel Aviv University has discovered a significant mutation in a LINC family protein - part of the cells of the inner ear - that could lead to new treatments for hearing disorders.
Researchers aimed to determine whether maternal morbidities and adverse obstetrical outcomes were more frequent in pregnant women with COVID-19.
› Verified 1 days ago
Name | Highpoint Hospice |
---|---|
Location | 575 East Bledsoe Street Suite 9, Gallatin, Tennessee |
Hospice ID | 441513 |
Category | Freestanding Hospice |
Ownership Type | Other |
Profit Type | OTHER |
SSA county code | 820 |
News Archive
Researchers at Cincinnati Children's Hospital Medical Center have developed the first molecular test to diagnose eosinophilic esophagitis, a chronic upper gastrointestinal disorder. The incidence of EoE has skyrocketed since it was first characterized two decades ago.
VistaGen Therapeutics, Inc. and NuPotential, Inc. today announced that the National Heart, Lung and Blood Institute of the U.S. National Institutes of Health (NIH) has awarded to the companies a grant of approximately $500,000 to accelerate development of novel and safer approaches to generate patient-specific induced pluripotent stem (iPS) cells for regenerative medicine, drug discovery and drug rescue.
Tumor burden plays an independent prognostic and predictive role in metastatic renal cell carcinoma, a clinical trial shows.
Because half of all instances of hearing loss are linked to genetic mutations, advanced gene research is an invaluable tool for uncovering causes of deafness - and one of the biggest hopes for the development of new therapies. Now Prof. Karen Avraham of the Sackler Faculty of Medicine at Tel Aviv University has discovered a significant mutation in a LINC family protein - part of the cells of the inner ear - that could lead to new treatments for hearing disorders.
Researchers aimed to determine whether maternal morbidities and adverse obstetrical outcomes were more frequent in pregnant women with COVID-19.
› Verified 1 days ago
NPI Number | 1073058111 |
Organization Name | Tennessee In-home Partner-ii, Llc |
Address | 300 Steam Plant Rd Gallatin, Tennessee, 37066 |
Phone Number | (615)328-6690 |
News Archive
Researchers at Cincinnati Children's Hospital Medical Center have developed the first molecular test to diagnose eosinophilic esophagitis, a chronic upper gastrointestinal disorder. The incidence of EoE has skyrocketed since it was first characterized two decades ago.
VistaGen Therapeutics, Inc. and NuPotential, Inc. today announced that the National Heart, Lung and Blood Institute of the U.S. National Institutes of Health (NIH) has awarded to the companies a grant of approximately $500,000 to accelerate development of novel and safer approaches to generate patient-specific induced pluripotent stem (iPS) cells for regenerative medicine, drug discovery and drug rescue.
Tumor burden plays an independent prognostic and predictive role in metastatic renal cell carcinoma, a clinical trial shows.
Because half of all instances of hearing loss are linked to genetic mutations, advanced gene research is an invaluable tool for uncovering causes of deafness - and one of the biggest hopes for the development of new therapies. Now Prof. Karen Avraham of the Sackler Faculty of Medicine at Tel Aviv University has discovered a significant mutation in a LINC family protein - part of the cells of the inner ear - that could lead to new treatments for hearing disorders.
Researchers aimed to determine whether maternal morbidities and adverse obstetrical outcomes were more frequent in pregnant women with COVID-19.
› Verified 1 days ago
NPI Number | 1558316125 |
Organization Name | Sumner Homecare And Hospice, Llc |
Address | 575 E Bledsoe St Gallatin, Tennessee, 37066 |
Phone Number | (615)328-5515 |
News Archive
Researchers at Cincinnati Children's Hospital Medical Center have developed the first molecular test to diagnose eosinophilic esophagitis, a chronic upper gastrointestinal disorder. The incidence of EoE has skyrocketed since it was first characterized two decades ago.
VistaGen Therapeutics, Inc. and NuPotential, Inc. today announced that the National Heart, Lung and Blood Institute of the U.S. National Institutes of Health (NIH) has awarded to the companies a grant of approximately $500,000 to accelerate development of novel and safer approaches to generate patient-specific induced pluripotent stem (iPS) cells for regenerative medicine, drug discovery and drug rescue.
Tumor burden plays an independent prognostic and predictive role in metastatic renal cell carcinoma, a clinical trial shows.
Because half of all instances of hearing loss are linked to genetic mutations, advanced gene research is an invaluable tool for uncovering causes of deafness - and one of the biggest hopes for the development of new therapies. Now Prof. Karen Avraham of the Sackler Faculty of Medicine at Tel Aviv University has discovered a significant mutation in a LINC family protein - part of the cells of the inner ear - that could lead to new treatments for hearing disorders.
Researchers aimed to determine whether maternal morbidities and adverse obstetrical outcomes were more frequent in pregnant women with COVID-19.
› Verified 1 days ago
NPI Number | 1942521166 |
Organization Name | Sumner Regional Medical Center Llc |
Address | 575 E Bledsoe St Gallatin, Tennessee, 37066 |
Phone Number | (615)328-5515 |
News Archive
Researchers at Cincinnati Children's Hospital Medical Center have developed the first molecular test to diagnose eosinophilic esophagitis, a chronic upper gastrointestinal disorder. The incidence of EoE has skyrocketed since it was first characterized two decades ago.
VistaGen Therapeutics, Inc. and NuPotential, Inc. today announced that the National Heart, Lung and Blood Institute of the U.S. National Institutes of Health (NIH) has awarded to the companies a grant of approximately $500,000 to accelerate development of novel and safer approaches to generate patient-specific induced pluripotent stem (iPS) cells for regenerative medicine, drug discovery and drug rescue.
Tumor burden plays an independent prognostic and predictive role in metastatic renal cell carcinoma, a clinical trial shows.
Because half of all instances of hearing loss are linked to genetic mutations, advanced gene research is an invaluable tool for uncovering causes of deafness - and one of the biggest hopes for the development of new therapies. Now Prof. Karen Avraham of the Sackler Faculty of Medicine at Tel Aviv University has discovered a significant mutation in a LINC family protein - part of the cells of the inner ear - that could lead to new treatments for hearing disorders.
Researchers aimed to determine whether maternal morbidities and adverse obstetrical outcomes were more frequent in pregnant women with COVID-19.
› Verified 1 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 98.0 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 99.4 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 83.5 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 100.0 | 97.3 |
Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 96.7 | 93.3 |
News Archive
Researchers at Cincinnati Children's Hospital Medical Center have developed the first molecular test to diagnose eosinophilic esophagitis, a chronic upper gastrointestinal disorder. The incidence of EoE has skyrocketed since it was first characterized two decades ago.
VistaGen Therapeutics, Inc. and NuPotential, Inc. today announced that the National Heart, Lung and Blood Institute of the U.S. National Institutes of Health (NIH) has awarded to the companies a grant of approximately $500,000 to accelerate development of novel and safer approaches to generate patient-specific induced pluripotent stem (iPS) cells for regenerative medicine, drug discovery and drug rescue.
Tumor burden plays an independent prognostic and predictive role in metastatic renal cell carcinoma, a clinical trial shows.
Because half of all instances of hearing loss are linked to genetic mutations, advanced gene research is an invaluable tool for uncovering causes of deafness - and one of the biggest hopes for the development of new therapies. Now Prof. Karen Avraham of the Sackler Faculty of Medicine at Tel Aviv University has discovered a significant mutation in a LINC family protein - part of the cells of the inner ear - that could lead to new treatments for hearing disorders.
Researchers aimed to determine whether maternal morbidities and adverse obstetrical outcomes were more frequent in pregnant women with COVID-19.
› Verified 1 days ago
Home Health Aides | 2 |
Counselors | 1 |
Medical Social Workers | 1.5 |
Physicians | 1 |
Registered Nurses | 8 |
Other Personnel | 5.5 |
Total Employees | 19 |
---|
News Archive
Researchers at Cincinnati Children's Hospital Medical Center have developed the first molecular test to diagnose eosinophilic esophagitis, a chronic upper gastrointestinal disorder. The incidence of EoE has skyrocketed since it was first characterized two decades ago.
VistaGen Therapeutics, Inc. and NuPotential, Inc. today announced that the National Heart, Lung and Blood Institute of the U.S. National Institutes of Health (NIH) has awarded to the companies a grant of approximately $500,000 to accelerate development of novel and safer approaches to generate patient-specific induced pluripotent stem (iPS) cells for regenerative medicine, drug discovery and drug rescue.
Tumor burden plays an independent prognostic and predictive role in metastatic renal cell carcinoma, a clinical trial shows.
Because half of all instances of hearing loss are linked to genetic mutations, advanced gene research is an invaluable tool for uncovering causes of deafness - and one of the biggest hopes for the development of new therapies. Now Prof. Karen Avraham of the Sackler Faculty of Medicine at Tel Aviv University has discovered a significant mutation in a LINC family protein - part of the cells of the inner ear - that could lead to new treatments for hearing disorders.
Researchers aimed to determine whether maternal morbidities and adverse obstetrical outcomes were more frequent in pregnant women with COVID-19.
› Verified 1 days ago
Highpoint Hospice Location: 575 East Bledsoe Street Suite 9, Gallatin, Tennessee, 37066 Phone: (615) 532-8669 |